DE60325586D1 - Mycobakterielle Proteinantigene für Krebstherapie und Impfung - Google Patents
Mycobakterielle Proteinantigene für Krebstherapie und ImpfungInfo
- Publication number
- DE60325586D1 DE60325586D1 DE60325586T DE60325586T DE60325586D1 DE 60325586 D1 DE60325586 D1 DE 60325586D1 DE 60325586 T DE60325586 T DE 60325586T DE 60325586 T DE60325586 T DE 60325586T DE 60325586 D1 DE60325586 D1 DE 60325586D1
- Authority
- DE
- Germany
- Prior art keywords
- vaccination
- protein antigens
- cancer therapy
- mycobacterial protein
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 102000036639 antigens Human genes 0.000 title abstract 2
- 108091007433 antigens Proteins 0.000 title abstract 2
- 238000002255 vaccination Methods 0.000 title abstract 2
- 238000011275 oncology therapy Methods 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 201000011510 cancer Diseases 0.000 abstract 2
- 101100071585 Caenorhabditis elegans hsp-16.2 gene Proteins 0.000 abstract 1
- 201000009030 Carcinoma Diseases 0.000 abstract 1
- 241001446467 Mama Species 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 238000009169 immunotherapy Methods 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 206010044412 transitional cell carcinoma Diseases 0.000 abstract 1
- 208000023747 urothelial carcinoma Diseases 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001176—Heat shock proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Oncology (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03019169A EP1508338B1 (de) | 2003-08-22 | 2003-08-22 | Mycobakterielle Proteinantigene für Krebstherapie und Impfung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE60325586D1 true DE60325586D1 (de) | 2009-02-12 |
Family
ID=34042896
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60325586T Expired - Lifetime DE60325586D1 (de) | 2003-08-22 | 2003-08-22 | Mycobakterielle Proteinantigene für Krebstherapie und Impfung |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1508338B1 (de) |
| AT (1) | ATE419003T1 (de) |
| DE (1) | DE60325586D1 (de) |
| ES (1) | ES2320538T3 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2821221A1 (de) * | 2013-07-04 | 2015-01-07 | PetroplastVinora AG | Peelfähige Folie |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6517839B1 (en) * | 1997-07-18 | 2003-02-11 | The Regents Of The University Of California | Methods for inducing interleukin-12 and a type1/Th1 T-cell response |
| AU2594500A (en) * | 1998-12-24 | 2000-07-31 | Corixa Corporation | Methods for using mycobacterium tuberculosis molecules as immunological adjuvants |
-
2003
- 2003-08-22 EP EP03019169A patent/EP1508338B1/de not_active Expired - Lifetime
- 2003-08-22 ES ES03019169T patent/ES2320538T3/es not_active Expired - Lifetime
- 2003-08-22 DE DE60325586T patent/DE60325586D1/de not_active Expired - Lifetime
- 2003-08-22 AT AT03019169T patent/ATE419003T1/de active
Also Published As
| Publication number | Publication date |
|---|---|
| ATE419003T1 (de) | 2009-01-15 |
| EP1508338B1 (de) | 2008-12-31 |
| ES2320538T3 (es) | 2009-05-25 |
| EP1508338A1 (de) | 2005-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE440107T1 (de) | Tumorassoziierte peptide, die hla klasse i oder ii-moleküle binden, und anti-tumor impfstoffe | |
| MX2007003402A (es) | Composicion inmunogena para su uso en vacunacion contra estafilococos. | |
| ATE388164T1 (de) | Tumor-assoziierte peptide, welche an unterschiedliche menschliche leukozytenantigene der klasse ii binden | |
| NO20015073D0 (no) | Vaksiner | |
| WO2006081007A3 (en) | Use of flagellin in tumor immunotherapy | |
| ATE421533T1 (de) | Immunogene t-helfer epitope von menschlichen tumorantigenen und deren verwendung in immunotherapeutischen methoden | |
| ATE546153T1 (de) | Kombinationen von tumor-assoziierten antigenen zur behandlung von verschiedenen krebstypen | |
| DK1350839T3 (da) | Identificering af de virulensassocierede regioner RD1 og RD5, hvilket muliggør udvikling af forbedrede vacciner af M. bovis BCG og M. microti | |
| WO2005007673A3 (en) | Immunogenic peptides | |
| CR9097A (es) | Formulaciones inmunoterapeuticas para la induccion de autoanticuerpos bloqueadores de la union de interleucina-2 a su receptor. su uso en tratamiento del cancer | |
| ATE525401T1 (de) | Vom tumorantigen 5t4 abgeleitete mhc-klasse-i- und ii-peptidantigene | |
| ATE419003T1 (de) | Mycobakterielle proteinantigene für krebstherapie und impfung | |
| AR022662A1 (es) | Acidos nucleicos y proteinas del gen mhp3 de mycoplasma hyopneumoniae y sus usos | |
| UY29216A1 (es) | Formulaciones inmunoterapeúticas para la inducción de autoanticuerpos bloqueadores de la unión de interleucina-2 a su receptor. su uso en el tratamiento del cáncer | |
| TH83896A (th) | สูตรในการสร้างภูมิคุ้มกันเพื่อก่อให้เกิดออโตแอนติบอดีที่สามารถหลีกเลี่ยงการเชื่อมต่อของอินเตอร์ลิวคิน-2 เข้ากับตัวรับของตัวเอง การใช้สูตรในการบำบัดรักษาโรคมะเร็ง |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8327 | Change in the person/name/address of the patent owner |
Owner name: LIONEX DIAGNOSTICS & THERAPEUTICS GMBH, 38124 , DE |